BRPI0908518A2 - formulação tópica de doses fixa estável, e, uso da formulação tópica de dose fixa estável - Google Patents

formulação tópica de doses fixa estável, e, uso da formulação tópica de dose fixa estável

Info

Publication number
BRPI0908518A2
BRPI0908518A2 BRPI0908518A BRPI0908518A BRPI0908518A2 BR PI0908518 A2 BRPI0908518 A2 BR PI0908518A2 BR PI0908518 A BRPI0908518 A BR PI0908518A BR PI0908518 A BRPI0908518 A BR PI0908518A BR PI0908518 A2 BRPI0908518 A2 BR PI0908518A2
Authority
BR
Brazil
Prior art keywords
fixed dose
topical formulation
stable fixed
dose topical
stable
Prior art date
Application number
BRPI0908518A
Other languages
English (en)
Inventor
Akhilesh Dayanand Sharma
Girish Ramakrishna Trivedi
Nitin Babulal Bhamre
Prashant Dongre
Sunil Sudhakar Chaudhari
Ulhas Rameshchandra Dhuppad
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of BRPI0908518A2 publication Critical patent/BRPI0908518A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
BRPI0908518A 2008-03-17 2009-03-13 formulação tópica de doses fixa estável, e, uso da formulação tópica de dose fixa estável BRPI0908518A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN532MU2008 2008-03-17
US4214208P 2008-04-03 2008-04-03
IN2570MU2008 2008-12-10
US14117508P 2008-12-29 2008-12-29
PCT/IN2009/000173 WO2009116086A2 (en) 2008-03-17 2009-03-13 Stable fixed dose topical formulation

Publications (1)

Publication Number Publication Date
BRPI0908518A2 true BRPI0908518A2 (pt) 2015-09-29

Family

ID=54199451

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908518A BRPI0908518A2 (pt) 2008-03-17 2009-03-13 formulação tópica de doses fixa estável, e, uso da formulação tópica de dose fixa estável

Country Status (9)

Country Link
US (1) US8673356B2 (pt)
EP (1) EP2265268A4 (pt)
BR (1) BRPI0908518A2 (pt)
CA (1) CA2717899A1 (pt)
IN (1) IN266834B (pt)
MX (1) MX2010010111A (pt)
RU (1) RU2497515C2 (pt)
WO (1) WO2009116086A2 (pt)
ZA (1) ZA201006849B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2717899A1 (en) 2008-03-17 2009-09-24 Glenmark Pharmaceuticals Limited Stable fixed dose topical formulation
US9636353B2 (en) 2010-10-21 2017-05-02 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
US10028972B2 (en) 2010-10-21 2018-07-24 Cadila Healthcare Limited Pharmaceutical compositions of anti-acne agents
US9254257B2 (en) 2010-10-21 2016-02-09 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin
WO2013019974A1 (en) * 2011-08-02 2013-02-07 Medicis Pharmaceutical Corporation Compositions comprising a retinoid and a lincosamide antibiotic for use in treating rosacea
CN110279887B (zh) * 2019-07-18 2021-12-14 王月玲 一种多用途光子冷凝胶及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955109A (en) 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US6462064B1 (en) * 1996-07-08 2002-10-08 Galderma Research & Development S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
ITBS20010111A1 (it) * 2001-12-20 2003-06-20 Paoli Ambrosi Gianfranco De Composizione per uso topico a base dell'estere etilico dell'acido linoleico e e del trietil estere dell'acido citrico associati con opportun
KR20070091613A (ko) 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
CA2717899A1 (en) 2008-03-17 2009-09-24 Glenmark Pharmaceuticals Limited Stable fixed dose topical formulation

Also Published As

Publication number Publication date
WO2009116086A2 (en) 2009-09-24
EP2265268A4 (en) 2011-07-13
MX2010010111A (es) 2010-12-15
EP2265268A2 (en) 2010-12-29
ZA201006849B (en) 2011-06-29
US20100068284A1 (en) 2010-03-18
IN266834B (pt) 2015-06-05
RU2010138947A (ru) 2012-04-27
RU2497515C2 (ru) 2013-11-10
CA2717899A1 (en) 2009-09-24
WO2009116086A3 (en) 2009-12-10
US8673356B2 (en) 2014-03-18

Similar Documents

Publication Publication Date Title
BRPI0914863A2 (pt) formulação tópica estável, e, uso da mesma
BRPI0820899A2 (pt) Formulação cosmética, e, uso da composição
BR112013016772A2 (pt) composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado
BRPI0921699A2 (pt) complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo
BRPI0821732A2 (pt) Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
BRPI0913726A2 (pt) rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos
BR112012003842A2 (pt) composição farmacêutica, método de formulação e uso da mesma
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014014763A2 (pt) novos conjugados de anticorpo-medicamento (adcs) e uso dos mesmos
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0906576A2 (pt) Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer
BRPI0920355A2 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BR112013014189A8 (pt) composição farmacêutica, uso de um agente de potencialização e uso de uma composição
IT1398268B1 (it) Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico
BRPI0908518A2 (pt) formulação tópica de doses fixa estável, e, uso da formulação tópica de dose fixa estável
FR2954943B1 (fr) Derives de pyridino-pyridinones arylsulfonamides, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]